Skip to Content

A novel prognostic marker associated with superior patient survival in soft tissue sarcoma

Checkpoint inhibitors are slowly being introduced in the care of specific sarcoma subtypes such as undifferentiated pleomorphic sarcoma. The present study explores the hypothesis that CD11c+ APCs in direct cell–cell contact with CD8+ T cells at the tumor site are associated with an active anti-tumor immune microenvironment and favorable prognosis. In this MEDtalk Monika Ehnma, Department of Oncology-Pathology, Karolinska Institute, present the result of the study.

Avaa artikkeli

Jos olet lääkäri, sairaanhoitaja tai muu terveydenhuollon ammattilainen, voit käyttää koko artikkelia luomalla profiilin BestPractice Nordic -sivustolle.

Back to top